Will Zepatier by Merck Monopolize Hepatitis C Market?

Will Zepatier by Merck Monopolize Hepatitis C Market? In October 2014, Gilead launched Harvoni to cover more market in a single-tablet formulation. With Harvoni's launch, the need for the interferon has been completely eliminated. The miracle drug reduced the treatment … Continue reading

Slides Now Available! 2015 APHA Special Session: The Changing Epidemiology of

Slides Now Available! 2015 APHA Special Session: The Changing Epidemiology of … Curative hepatitis C therapies need to be more affordable and accessible to all. Dr. Holmberg underscored the importance of adopting an effective strategy to ensure that access to … Continue reading

Hep C Treatment for All Genotypes Granted Priority Review

Hep C Treatment for All Genotypes Granted Priority Review “As the first fixed-dose combination of 2 pan-genotypic, direct-acting antivirals, SOF/VEL [sofosbuvir/velpatasvir] represents an important step forward in the treatment of patients with hepatitis C,” said Norbert Bischofberger, executive vice … … Continue reading